Procare Health lance Dolocare Flexthe new one natural option based bio-optimized turmeric for the management of patients with Joint pain caused by diseases such as osteoarthritis and that is supported by multiple clinical studies.
The osteoarthritis is a complex disease and of higher prevalence in women (30% of the Spanish population suffers from it) and the determinants of osteoarthritis in Spain are age, female gender and obesity. This is reflected in the latest data obtained from the study of the Spanish Society of Rheumatology EPISER2016.
As highlighted by the Dr. Josep Vergéspresident and CEO of the foundation (Osteoarthritis Foundation International), the first foundation for people with osteoarthritis worldwide, “Despite its social impact, osteoarthritis is perceived as a disease associated with old age. But the reality is that It doesn’t just affect older people.. With the increase in life expectancy and the change towards a society with a more active lifestyle, greater practice of sports, etc., cases of osteoarthritis are beginning to be detected in other younger risk groups such as athletes”.
One Dolocare Flex capsule is equivalent to ingesting 950 grams of almost one kilo of turmeric powder
The final cause and mechanism of osteoarthritis is generally unknown and, therefore, the goal of treatment is reduce pain, inflammation and disease progression. This can be addressed with non-pharmacological measures (exercise, postural hygiene, etc.) and pharmacological measures, depending on the severity of the osteoarthritis and at the discretion of the health professionals, such as taking painkillers, NSAIDs (Non-Steroidal Anti-Inflammatory), opioids or surgery in case of terminal stage.
The consumption of this type of drugs, such as opioids, has grown remarkably in the last 7 years and has put in alert the Spanish administrations. Also, the continued use of NSAIDs or pain relievers such as paracetamol increases the risk of suffering side effects that, ultimately, have a negative impact on the quality of life of these patients.
“The reality of the arthritic patient who commonly uses chronic drug treatments is that, although they are highly effective, you are exposed to the inconvenience or inconvenience that these can produce, such as the gastrointestinal risk that exists with some drugs or the slow or delayed action of others”, explains the Dr. Jordi Monforthead of the rheumatology service at Hospital del Mar in Barcelona.
A therapeutic solution of natural origin
In this sense, a laboratory with extensive experience in the osteoarticular health and focused on the search for therapeutic solutions of natural origin based on scientific evidence, adds to its range of products the new Dolocare Flex.
“Dolocare Flex is neither more nor less than bio-optimized turmeric. Turmeric is the root of the Curcuma longa plant, which is traditionally used to alleviate joint pain. The therapeutic potential of turmeric lies in its active ingredient, curcumin. The mechanism of action of curcumin is supported by more than 6,000 scientific publications in the last 5 years. Its action is anti-inflammatory and consequently, reduces joint pain“, Explain Yann GaslainFounding CEO of Procare Health.
The problem with turmeric (in short, curcumin) is its low absorption by the body. If it is not absorbed, it will hardly exert its action and it will be eliminated quickly. “One capsule of Dolocare Flex is equivalent to ingesting 950 galmost a kilo of turmeric powder that you buy in the supermarketGaslain clarifies.
“We have multiple clinical studies with Dolocare Flex in patients with osteoarthritis. One of the most important and that has been recently published by a journal of high scientific impact is the COPRA studywhich was also accepted by the European Congress of Rheumatology last year (EULAR, European League of Rheumatism). This is one of the strongest points of our product, which has been accepted by health professionals such as rheumatologists and traumatologists.”, clarifies the CEO of Procare Health.
The COPRA study was conducted in 150 patients between 45 and 80 years with , being regular users of paracetamol and/or NSAIDs for pain management. The first and the third month of treatment with Dolocare Flex were evaluated and it was observed, both at the first and the third month of treatment with Dolocare Flex, a significant reduction in pain, and an improvement in the quality of life of patients.
The most impressive result of this study, apart from the reduction in pain, is the NSAID dose reduction during treatment. Nearly half of the patients stopped taking NSAIDs, showing the beneficial effect of Dolocare Flex in patients who use this medication chronically, helping to reduce the possible adverse effects that they may suffer.
But clinical studies are not only focused on the efficacy of Dolocare Flex in knee osteoarthritis pain, which is the most common pain caused by the disease, but also the same pain reduction results have been shownless use of NSAIDs and/or analgesics and improvement in the quality of life in patients with osteoarthritis in different locations such as shoulders, hips, hands, spine or neck.